Therapieintensivierung bei Typ-2-Diabetespatienten mit basalunterstützter oraler Therapie (BOT): Bessere klinische Ergebnisse mit iGlarLixi vs. BIAsp 30 in der SoliMix-Studie. (German)

Autor: Rosenstock, Julio, Seufert, Jochen, Emral, Rifat, Reyna, Leobardo Sauque, Mohan, Viswanathan, Trescolí, Carlos, Sifri, Saud Al, Lalic, Nebojsa, Alvarez, Agustina, Picard, Pascaline, Demil, Nacima, Bonnemaire, Mireille, McCrimmon, Rory J.

Publikováno v: Diabetologie und Stoffwechsel; 2022 Supplement, Vol. 17, pS24-S24, 1p

Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals.

Autor: Moazin MS; Assistant Professor of Urology, King Saud University for Health Science, Riyadh, Saudi Arabia., Baazeem A; Associate Professor of Urology, Umm Al-Qura University, Makkah, Saudi Arabia., Al-Bakri A; Urology consultant, Male Reproductive Health specialist, Security Forces Hospital, Riyadh, Saudi Arabia., Dayel AA; Consultant Urologist/Andrologist, Director of Men's Health Clinic, Dammam, Saudi Arabia., Amir A; Consultant Family Medicine, International Medical Center, Jeddah, Saudi Arabia., Sifri SA; Consultant Endocrinologist, Department of Endocrinology & Diabetes, Alhada Armed Forces Hospital, Taif, Saudi Arabia., Reda M; Professor of Psychiatry, Ain Shams University, Cairo, Egypt., Bashraheel F; Urologist/Andrologist, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia., Alfakhri A; Consultant Andrology/Male Infertility, King Fahad Medical City - Main Hospital, Riyadh, Saudi Arabia., Hamdy Y; Medical Advisor, Viatris, Riyadh, Saudi Arabia., Elshaer F; Professor of Cardiology, King Fahad cardiac center, King Khaled university hospital, King Saud university, Riyadh, Saudi Arabia- National heart institute, Cairo, Egypt.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2024 Jul; Vol. 13 (7), pp. e230155. Date of Electronic Publication: 2024 May 22.